12.07.2015 Views

ECMO and Continuous Renal Replacement Therapy - PPAG

ECMO and Continuous Renal Replacement Therapy - PPAG

ECMO and Continuous Renal Replacement Therapy - PPAG

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Volume of Distribution• <strong>ECMO</strong> requires the addition exogenous bloodproducts to prime the circuit• Increases circulating blood volume <strong>and</strong> overallvolume of distribution• Some cases more than doubles normal blood volume• Can have effects on the volume ofdistribution of medications• More significant in neonates than in pediatric<strong>and</strong> adolescent patients• Especially significant for drugs primarilydistributed in the central compartment• Low population V dCHB prime packs• Albumin• Shown to decrease drug adsorption• An electrolyte solution <strong>and</strong> Albumin are added tocircuit after the CO 2 prime <strong>and</strong> before the bloodproduct prime• Neonatal Pac• 500 mL CMV negative PRBCs

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!